• Like
  • Comment
  • Favorite

Moderna, Pfizer Stocks Fall After Reports of RFK Jr. Nomination -- WSJ

Dow Jones11-15

By Jasmine Li

Shares of vaccine-makers fell after reports that Donald Trump is expected to nominate vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

Shares of Moderna $(MRNA)$ and Pfizer dropped almost immediately after the initial report by Politico, then rebounded slightly. As of Thursday's market close, Moderna's stock fell 5.6% and Pfizer $(PFE)$ was down 2.6%.

"We're not going to take vaccines away from anybody," Kennedy said in an interview following Trump's victory.

Here's the Wall Street Journal article on Trump's expected appointment of RFK Jr.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

November 14, 2024 16:31 ET (21:31 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

empty
No comments yet
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial